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Retinitis pigmentosa (RP) is an inherited photoreceptor 
degenerative disease that leads to blindness. The disease is 
often caused by mutations in rod photoreceptor (PR) specific 
genes resulting in initial loss of night vision. However, once 
a certain threshold of rod death is breached [1], secondary 
cone death follows leading to the loss of daylight, color, and 
high-acuity vision [2]. Understanding the underlying cause of 
secondary cone death may allow for the development of treat-
ments that are applicable to all individuals with mutations in 
rod-specific genes. For example, the identification of a cell 
death mechanism could be exploited to prevent the execution 
of cone death itself.
Caspases belong to a family of cysteine proteases that 
control and execute apoptosis, which is a form of controlled 
cell death that leads to the removal of compromised cells 
within a tissue [3]. Caspases can be subdivided into initiator 
and executioner caspases and are generally activated by 
specific cell intrinsic or extrinsic signals or insults [4-6]. 
Thus, identifying a specific caspase as part of a cell death 
mechanism can give insights into the underlying cause for 
cell death. For example, we have previously proposed that 
secondary cone loss in RP is caused by a glucose and thus, 
NADPH, shortage in cones, which is elicited by structural 
changes induced by the loss of the overabundant rods [1]. By 
improving cell metabolism in cones through activation of the 
mammalian target of rapamycin complex 1 (mTORC1), we 
showed that cone survival is improved, and retinal NADPH 
levels are increased [1,7-10]. Consistent with that result, we 
found that loss of the NADPH-sensitive initiator Caspase-2 
delays cone death in the rd1 mouse model of RP, a mouse 
model that carries a mutation in the rod PR specific phospho-
diesterase 6-beta gene (PDE6b) [7,11]. Similarly, loss of the 
executioner Casp7 delays rod degeneration in the autosomal 
dominant Rhodopsin T17M mouse model of RP [12]. Interest-
ingly, Casp7 is enriched in cones and expressed in the inner 
nuclear layer but is absent in adult rods [13]. However, in 
the case of the T17M mutant, which triggers endoplasmic 
reticulum (ER) stress and activation of the unfolded protein 
response (UPR), Casp7 is upregulated in rods [12,14]. Other 
autosomal dominant mutations in Rhodopsin, such as the 
S334ter and the P23H, have also been shown to lead to ER 
stress, yet the protective effect of loss of Casp7 in these 
mutants has not been tested [15,16]. Activation of Casp7 has 
also been shown to occur for some cone-specific mutations, 
such as mutations in cyclic nucleotide-gated channel subunits 
alpha 3 and beta 3 (CNGA3 and CNGB3) [17]. Mutation in 
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Purpose: The apoptotic mechanisms responsible for secondary cone death in retinitis pigmentosa (RP) remain largely 
unknown. The cone-enriched apoptotic protease caspase-7 (Casp7) is thought to be triggered by endoplasmic reticulum 
(ER) stress and plays a pivotal role in mice deficient in the cone cyclic nucleotide-gated channels, a deficiency that causes 
achromatopsia in humans and in mice with autosomal dominant rhodopsin mutations, in particular the T17M mutation. 
Thus, we tested in two mouse models of RP whether the cone-enriched Casp7 plays a role during secondary cone death.
Methods: Casp7 knockout mice were crossed to two different RP mouse models with significantly different rod and 
cone death kinetics: the rd1 mouse model, which carries a mutation in the Pde6b gene, and the rhodopsin knockout 
mouse model (Rho-KO or Rho–/–). In both models, cone survival was assessed on retinal flat mounts by quantifying the 
percentage of cone arrestin staining over the retinal surface area. The analyses were performed at two different time 
points for each model.
Results: Loss of Casp7 did not alter cone survival in either of the two mouse models tested regardless of the time point 
analyzed. Rod survival was also not affected in either model nor did loss of Casp7 affect rod or cone function in a wild-
type background as assessed with electroretinogram analyses.
Conclusions: Secondary cone death in retinitis pigmentosa is unlikely to be triggered by ER stress and is likely inde-
pendent of Casp7 activity.
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either gene has also been associated with ER stress and acti-
vation of the UPR. The fact that Casp7 appears to be involved 
in rod and cone cell death when either cell experiences ER 
stress led us to test whether Casp7 may also play a role during 
the periods of secondary cone degeneration in RP, particu-
larly because Casp7 is cone enriched and ER stress has been 
predicted to contribute to cone death in RP. Further, loss of 
caspase-2 did not completely prevent cone death; instead, the 
loss delayed cone death [7,13,18]. Thus, other yet unidentified 
cell death mechanisms are likely involved in triggering cone 
death in RP. Such a mechanism could involve ER stress–
mediated activation of CASP7, because ER stress can also be 
triggered by increased oxidative stress, a condition known to 
be present during cone degeneration in RP and when allevi-
ated, delays cone death [19-24].
METHODS
Animals: All procedures involving animals were in compli-
ance with the Association for Research in Vision and 
Ophthalmology (ARVO) Statement for the Use of Animals 
in Ophthalmic and Vision Research and were approved by 
the Institutional Animal Care and Use Committees (IACUC) 
of the University of Massachusetts Medical School. Animals 
were maintained on a 12 h:12 h light-dark cycle with unre-
stricted access to food and water. Lighting conditions were 
kept constant in all cages, with illumination ranging between 
10 and 15 lux. The Pde6b–/– (rd1, FVB strain), C57BL/6J, 
Casp7–/–, and Casp2–/– mice were purchased from Jackson 
Laboratories (Bar Harbor, ME) [11,25,26]. Because the FVB 
strain that carries the rd1 mutation is albino, it was first 
backcrossed to C57BL/6J for ten generations to generate 
the rd1_C57BL/6J line [7]. The Casp7–/– was already on a 
C57BL/6J, and the Rho–/– mice, which have been described 
previously by Janis Lem [27], are also maintained on a 
C57BL/6J background. However, to avoid any possible strain 
background differences and to be able to directly compare 
littermates, we first generated heterozygous Casp7 siblings 
(F1: e.g., Casp7–/+_Rho–/–) that were then crossed to each 
other to obtain the two (e.g., Casp7–/–_Rho–/– versus Rho–/–) 
of the three possible different genetic combinations of the F2 
cross that were then used for analysis. For the triple loss of 
function of Casp7–/–_Casp2–/–_rd1, we generated the desired 
genotype, analyzed the data at 20 weeks of age, and compared 
the data to our previously published data for the Casp2–/–_rd1 
genotype [7]. Genotyping was performed as described in the 
original publications. All mice were genotyped for absence 
of the rd8 allele with a mutation in the Crumbs 1 gene [28]. 
Electroretinography (ERG) was performed using the Espion 
E3 console in conjunction with the Color Dome (both sold by 
Diagnosys LLC, Lowell, MA) as described previously [29] 
with a minimum of six animals per genotype and age.
Histological methods: Antibody stainings on retinal f lat 
mounts were performed as described previously [7,30]. 
CASP7 activity on retinal whole mounts was detected 
using the FAM-FLICA Caspase 3 & 7 Assay Kit (Cat# 93) 
from ImmunoChemistry Technologies (Bloomington, MN) 
as previously described [7] following the manufacturer’s 
instructions. The following primary antibodies and concen-
trations were used: rabbit α-cone arrestin (1:500; Cat# 15,282) 
from EMD Millipore (Now: MilliporeSigma, Burlington, 
MA), f luorescein-labeled peanut agglutinin lectin (PNA; 
1:500; Cat# FL-1071) from Vector Laboratories (Burlingame, 
CA), and α-cleaved caspase 3 (1:300; Cat# 9662) from Cell 
Signaling (Danvers, MA). Nuclei were counterstained with 
4 ,´6-diamidino-2-phenylindole (DAPI; Cat# 9542) from 
Sigma-Aldrich (Now: MilliporeSigma, Burlington, MA). All 
secondary antibodies (donkey) were purchased from Jackson 
ImmunoResearch (West Grove, PA) and were purified F(ab)2 
fragments that displayed minimal cross-reactivity with other 
species. Quantification of cone survival was performed as 
previously described by calculating the surface area of the 
retina that is covered by the cone arrestin signal versus the 
entire retinal surface area to extrapolate the percentage of 
cone survival [1,7,9,31]. A minimum of six animals were 
used per genotype and age. Colocalization between the cone 
arrestin staining and the retinal surface area was calculated 
using CoLocalizer Pro software [32]. All images were 
acquired on a Leica DM5500 fluorescence microscope Leica 
(US Branch: Buffalo Grove, IL) equipped with an automated 
stage for tiling.
Molecular biology and cell culture methods: Protein extrac-
tions and western blot analysis were performed as described 
previously [7]. The following primary antibodies were used: 
rabbit α-caspase-7 (1:1,000; Cat# 9492) from Cell Signaling 
and mouse α-β-actin (1:2,000; Cat# A5316) from Sigma. 
To clone the Casp7 cDNA for overexpression Casp7 was 
amplified by PCR (For: 5’-GCG GCC GCC ACC ATG 
ACC GAT GAT CAG GAC TG-3’; Rev: 5’-CTA ACG GCT 
GAA GTA CAG CT-3’; PCR conditions: 95˚C for 2’; 25 
times: 95˚C for 15’’, 53˚C for 30’’, 68˚C for 1’) with TaKaRa 
(US Branch: Mountain View, CA) LA Taq (Cat# RR002A) 
from a C57BL/6J retinal cDNA library that was generated 
as previously described [1]. The PCR product (994 bp) was 
sub-cloned into the p-GEMT-Easy vector (Cat# A1360) 
Promega (Madison, WI) and sequence verified. The Casp7 
cDNA was then cloned into a recombinant adenoassociated 
virus (rAAV2) plasmid carrying a cytomegalovirus (CMV) 
promoter and the SV40 poly-adenylation site. The human 
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embryonic kidney (HEK 293) cells were either treated with 
100 nM rapamycin or transfected with Casp7 using PEI (Poly-
science Inc, Warrington, PA; Cat# 23,966). For all condi-
tions, cells were maintained in regular Dulbecco’s Modified 
Eagle Medium (DMEM; Cat# 11965092) containing 10% 
fetal bovine serum (FBS; Cat# 16140071) and a penicillin/
streptomycin mixture (Cat# 15140122) all from Gibco by Life 
Technology (now Thermo Fisher Scientific; Grand Island, 
NY). Twelve hours post rapamycin treatment and 24 h post 
transfection with Casp7, protein extractions were performed 
as described [7].
Statistical analysis: The Student t test was used for statistical 
analyses. P values of less than 0.05 were considered statis-
tically significant. None of the comparisons showed any 
statistically significant difference. All error bars represent 
the standard error of the mean (SEM).
RESULTS
Loss of Casp7 does not affect rod and cone function in a 
wild-type background: To study the long-term effect of Casp7 
loss on secondary cone death in RP, we first assessed whether 
Casp7 loss alone has any negative effect on cones and rods 
in a wild-type background. The Casp-7–/– mice showed no 
appreciable difference in rod and cone function by 20 weeks 
of age when compared to the wild-type C57BL/6J mice 
(Figure 1A,B). The expression of cone-specific proteins, such 
as cone arrestin, was unchanged in the Casp7–/– mice, and the 
retinal structure appeared indistinguishable from that in the 
wild-type mice (Figure 1C) indicating that the loss of Casp7 
has no overt effect on retinal development and function.
Casp7 loss does not alter rod survival in the rd1 and 
Rho-KO mouse models of RP: The endoplasmic reticulum 
stress induced Casp7 has been implicated in several auto-
somal dominant mouse models of RP [15,16], and the loss 
of this protein has been shown to delay rod death in the 
T17M rhodopsin mouse model of autosomal dominant RP 
[12]. Endoplasmic reticulum stress has also been proposed 
to contribute to retinal degeneration in the rd1 mouse model 
of retinal degeneration [18]. Because rod survival positively 
affects cone survival [1], we wanted to ensure that any effect 
of Casp7 loss on cones was not due to increased rod survival 
due to Casp7 loss in rods. Thus, we analyzed rod survival in 
rd1 and Rho-KO mice lacking Casp7 at 3 and 17 weeks of age, 
respectively. These time points were chosen as they coincide 
with the onset of cone death in these two mouse models of 
RP [1]. Therefore, any substantial increase in the number of 
surviving rods at the onset of cone death would inevitably 
delay cone death. Because at 3 and 17 weeks, respectively, the 
outer nuclear layer thickness in both models is reduced to one 
row of cells in the central retina, any difference in thickness 
would be clearly evident at those ages. No difference was seen 
in outer nuclear layer thickness on the retinal cross sections 
between the rd1 mice and the Casp7–/–_rd1 mice at 3 weeks of 
age indicating that rod survival was not altered in the absence 
of Casp7 (Figure 2A). Retinal flat mounts revealed a uniform 
distribution of cones as assessed with cone arrestin antibody 
Figure 1. Loss of Casp7 does not 
affect rod and cone function in 
a wild-type background. A, B: 
Electroretinogram (ERG) record-
ings at 20 weeks of age showing 
averages of b-wave amplitudes of 
scotopic ERGs over five different 
light intensities (A) and average 
of b-wave amplitudes of photopic 
ERGs (B) n=6 in A and B; Error 
bars: SEM. C: Immunof luores-
cence analysis on a cross section 
at 20 weeks of age showing normal 
expression of cone arrestin (red 
signal) and normal labeling of 
cone segment sheets with PNA 
(green signal). Blue: nuclear 
4 ,´6-diamidino-2-phenylindole (DAPI). (Blue and green signals were removed from one third of each panel to better visualize the cone 
arrestin staining.) Scale bar: 20 μm.
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staining consistent with 3 weeks being the onset of cone death 
(Figure 2B). Similarly, in the Casp7–/–_Rho-KO mice the outer 
nuclear layer was also reduced to one row of cells at 17 weeks 
of age indicating that also in the Rho-KO background the loss 
of CASP7 had no effect (Figure 2C). This is significantly 
different from what was seen in the T17M Rhodopsin mouse 
model where the thickness of the outer nuclear layer was three 
times wider [12]. In summary, loss of Casp7 did not affect rod 
survival in the rd1 and Rho-KO mouse models of RP.
Secondary cone death in not affected by loss of Casp7 in the 
rd1 and Rho-KO mouse models of RP: To determine whether 
Casp7 is activated in cones during the period of secondary 
cone death, we first used western blot analyses to test for 
cleaved Casp7. Executioner caspases are commonly activated 
by cleavage [33]; thus, the presence of a cleaved product is 
an indicator of an activated caspase. We did not detect any 
cleaved Casp7 in the rd1 mice (Figure 3A) although we 
readily identified the cleaved product in the HEK293 cells 
treated with rapamycin. However, Casp7 is the exception 
among the executioner caspases in that dimerization of 
Casp7 is sufficient for activation albeit at lower levels [34,35]. 
Consistent with that, overexpression of Casp7 in the HEK293 
cells was sufficient to cause enough dimerization of Casp7 
resulting in autocatalytic cleavage of the caspase (Figure 3A). 
Interestingly, the levels of CASP7 declined with the demise 
of cones over time consistent with it being enriched in cones. 
Alternatively, the decline could also be due to a decline in the 
number of cones in conjunction with an age-related decline 
in the inner nuclear layer and possibly in cones. To further 
test whether Casp7 was activated without cleavage, we used 
a fluorescein isothiocyanate (FITC)–labeled peptide with 
the target sequence of Casp7 (DEVD). The peptide becomes 
covalently bound to Casp7 only when the active site of the 
protease is formed. The fluorescent label thus allows deter-
mining if there is any in situ activity of Casp7 in cones. 
Although labeling of cones was seen in the 6-week-old rd1 
mice, labeling was not abolished in the Casp7–/–_rd1 mice 
(Figure 3B). Interestingly, most of the labeled cell had a more 
condensed nucleus with almost no expression of the cone-
specific protein cone arrestin consistent with the labeled cells 
undergoing apoptosis (Figure 3C). However, the same peptide 
can also bind to activated Casp3; thus, cross-reactivity cannot 
be excluded [36], although we were not able to detect any 
cleaved Casp3 in cones (data not shown) with an antibody that 
readily detected cleaved Casp3 in rods during the period of 
rod degeneration [1]. Finally, quantification of cone survival 
at 6 weeks and 20 weeks of age did not show any statistically 
Figure 2. Loss of Casp7 does 
not affect rod degeneration. A: 
Retinal cross section of 3-week-
old Casp7+/+_rd1 and Casp7–/_–rd1 
mice stained with 4 ,´6-diamidino-
2-phenylindole (DAPI) showing 
no difference in the thickness 
of the outer nuclear layer in the 
central retina (n = 3 animals; the 
zoomed-in view shows one row of 
cells above the dotted line which 
separated the outer nuclear layer 
from the inner nuclear layer). B: 
Retinal f lat mounts stained with 
cone arrestin (red signal) showing 
no difference in the distribution 
of cones at the onset of cone death 
(genotype and age same as in panel 
A). C: Retinal cross section of 
17-week-old Casp7+/+_Rho-KO and 
Casp7–/–_Rho-KO mice showing no 
difference in the thickness of the 
outer nuclear layer in the central 
retina (n = 3 animals; the dotted 
line separates the outer nuclear 
layer from the inner nuclear layer).
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significant difference between the rd1 mice and the rd1 mice 
with Casp7 loss (Figure 3D,E). Similarly, loss of Casp7 in the 
slower progressing Rho-KO mouse model of RP also did not 
result in any statistically significant difference in the distribu-
tion of cones at the onset of cone death, meaning at 17 weeks 
of age and at 30 weeks of age (Figure 4A,B). The 30 week 
time point, which is roughly equivalent to 10 weeks of age in 
the rd1 mouse model [1], was chosen as the second time point 
because by then cone death has progressed significantly in 
the Rho-KO. Cone function was also not changed although 
there was a slight reduction in the Casp7–/–_Rho-KO mice 
(Figure 4C). Overall, the data suggest that Casp7 likely does 
not contribute to secondary cone death in RP.
DISCUSSION
We set out to understand whether Casp7 is involved in 
facilitating secondary cone death during the periods of cone 
degeneration in RP. Because Casp7 is cone enriched and has 
been shown to play a role in PRs that experience ER stress, 
and ER stress has been proposed to be a contributing factor 
to PR death in RP, Casp7 was chosen as a rational candidate 
to identify additional cell death mechanisms that contribute 
to secondary cone death in RP [12,13,16-18]. Although we 
were able to detect activated Casp7 with the FITC-labeled 
activity-peptide assay, we did not identify any cleaved CASP7 
protein product nor was the peptide-activity assay negative 
in the Casp7–/–_rd1 background. Because the same peptide 
sequence used here also recognizes activated CASP3, cross-
reactivity to CASP3 cannot be excluded [36]. However, 
we failed to detect activated CASP3 in cones with immu-
nofluorescence although in our previously published work 
Figure 3. Loss of Casp7 does 
not affect cone death in the rd1 
mouse model of RP. A: Western 
blot analysis at postnatal (P) days 
21, 35, and 70 with retinal extracts 
from Casp7+/+_rd1 and Casp7–/–_rd1 
mice showing on the left no cleaved 
CASP7 protein in Casp7+/+_rd1 
mice, a decline in the CASP7 
protein over time, consistent with 
its enrichment in cones, and a lack 
of detectable CASP7 protein in 
Casp7–/–_rd1 mice. To the right, the 
western blot analysis with protein 
extracts from HEK293 cells show 
cleavage of the CASP7 protein after 
rapamycin treatment or overexpres-
sion of Casp7, indicating that the 
antibody is able to recognize the 
cleaved product and that dimeriza-
tion by overexpression is sufficient 
to activate CASP7 (the lines on the 
right of both western blots indicate 
molecular weight markers in kDa; 
starting from the top line, their respective sizes are 37, 25, 20, 15, 10; arrows on right side of the western blot point to pro-CASP7 while 
the arrow on the left of the western blot points to the cleaved CASP7 product). B: Immunofluorescence on retinal flat mounts to detect 
active CASP7 (the green signal indicates the fluorescein isothiocyanate (FITC)–labeled CASP7 activity peptide) in the Casp7+/+_rd1 and 
Casp7–/–_rd1 mice. Because the FITC signal is still present in Casp7–/_–rd1 mice, the peptide is likely cross-reacting. C: Higher magnification 
of the assay in (B) showing that cone cells strongly labeled by the FITC CASP7 activity peptide (arrowheads) tend to have pyknotic nuclei 
and less cone arrestin immunoreactivity (red signal), suggesting that the peptide was labeling dying cones (blue: nuclear 4 ,´6-diamidino-
2-phenylindole [DAPI]). D: Examples of retinal flat mounts of Casp7+/+_rd1 and Casp7–/–_rd1 mice stained for cone arrestin (red signal) 
expression at 6 and 20 weeks of age. E: Quantification of cone survival at 6 and 20 weeks of age showed no statistically significant improve-
ment in cone survival upon loss of Caspase-7 in rd1 mice. (n=6 per genotype and time point; Error bars: SEM).
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the antibody was able to detect activated CASP3 during the 
periods of rod degeneration [1]. This does not exclude that the 
FITC-labeled peptide-activity assay may have reacted with 
low levels of activated CASP3. Alternatively, the chemically 
activated FITC-labeled peptide could have reacted with other 
proteases or protein degradation products produced during 
the cell death process, because labeling with the FITC-
labeled peptide was preferentially seen in cells undergoing 
apoptosis. We favor this hypothesis over cross-reactivity with 
CASP3, because although CASP3 and CASP7 were for a long 
time believed to be functionally redundant, more and more 
research indicates that there are clear functional differences 
in vivo and regarding substrate recognition, indicating that 
these two proteases occupy distinct non-redundant roles 
within the cell death machinery [36-40].
We previously identified Casp2 as the first caspase that 
plays a pivotal role during the periods of secondary cone 
death in RP [7]. Thus, if Casp7 plays any role in secondary 
cone death, one could envision that in the absence of Casp7 
cones increase CASP2 activity. Such a scenario could offer 
an explanation for the cross-reactivity of the FITC-labeled 
peptide and the fact that loss of Casp7 did not result in 
improved cone survival. To determine whether in the absence 
of Casp7 Casp2 plays a more prominent role in secondary 
cone cell death, we also generated the double loss of function 
in an rd1 background and analyzed cone survival at 20 weeks 
of age, when we saw a clear improvement in our previously 
published data in the absence of Casp2 [7]. However, although 
at 20 weeks of age concomitant loss of Casp2 and Casp7 in 
an rd1 background resulted in improved cone survival when 
compared to the loss of Casp7 alone (30.9%±2.90% versus 
15.7%±1.00%, respectively), the double loss of function did 
not result in a statistically significant improvement in cone 
survival when compared to our previously published data [7] 
with the loss of Casp2 alone (31.5%±1.00%), suggesting that 
Casp2 does not compensate for the lack of Casp7.
The rd1 mouse model of RP is one of the fastest degen-
erating mouse models used to study the disease. Thus, it 
is quite possible that some mechanisms of cone cell death 
may be quite specific to this model and not apply to slower 
models of cone degeneration. To address this issue, we also 
used the much slower degenerating mouse model of RP, 
the Rho-KO mouse. Nonetheless, there was no difference 
in cone degeneration in the Rho-KO mouse model in the 
absence or presence of Casp7. In summary, Casp7 is either 
not involved in secondary cone death in RP or the effect of 
Casp7 is negligible. This is surprising given that Casp7 is 
expressed in cones and is absent from rods, albeit rods are 
perfectly capable of upregulating Casp7 under stress condi-
tions that cause ER stress [12,14]. This raises the question, 
why would cones express Casp7 rather than upregulating 
it when needed? One possible explanation could be that 
CASP7 can cleave CASP12. In its uncleaved form, CASP12 
can bind CASP1 and thus prevent CASP1-mediated activation 
of proinflammatory cytokines, such as interleukin (IL)-1β 
and IL-18 [41]. Thus, the presence of CASP7 in cones could 
accelerate the release of proinflammatory cytokines from 
cones after ischemia, light damage, or infection. However, 
the present findings allow us only to conclude that CASP7 
is not required for secondary cone death in RP suggesting 
Figure 4. Loss of Casp7 does not 
affect secondary cone death in 
Rho-KO mice. A: Examples of 
retinal f lat mounts of Casp7+/+_
Rho-KO and Casp7–/–_ Rho-KO 
mice stained for cone arrestin (red 
signal) expression at the onset 
of cone death (17 weeks) and a 
later time point (30 weeks) that 
corresponds to roughly 10 weeks 
in rd1 mice. B: Quantification of 
cone survival at 17 and 30 weeks 
of age of Casp7+/+_Rho-KO and 
Casp7–/–_Rho-KO mice. No statis-
tically significant improvement in 
cone survival is seen upon loss of 
Casp7. C: B-wave amplitudes of 
photopic electroretinogram recordings showed also no statistically significant improvement in cone function upon loss of Casp7. (n=6 per 
genotype and time point in B and C; Error bars: SEM).
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that under these conditions cone death is unlikely due to an 
increase in ER stress. Additionally, the findings suggest that 
the mechanism(s) used to execute secondary cone death in 
RP may be the same across all disease-causing mutations 
that are in genes exclusively expressed in rods, meaning the 
mechanisms are independent of the rod death kinetics.
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